Biography:

Dr Kang received her PhD degree in molecular medicine at the University of Auckland in 2011. She worked as a postdoctoral researcher at the Garvan Medical Research Institute, Sydney during 2011-2013. In 2013 she joined the research group of Prof. Rick Pearson at the Peter MacCallum Cancer Centre (Peter Mac), Melbourne to develop, characterize and optimize ribosome-targeting therapy. She is a Senior Research Officer at Peter Mac. She has published 29 research articles and made fundamental discoveries on oncogenic signaling transduction, ribosome biogenesis and mRNA translation in cancer.